IIPLA News
Thursday, May 14, 2026

USPTO Denies IPR Challenges to First Solar’s TOPCon Patents, Advancing Infringement Litigation

Inter Partes Review petitions filed by JinkoSolar, Mundra Solar, and Canadian Solar rejected, enabling First Solar to pursue patent infringement claims in Delaware federal court

IIPLA News Deskanonymous access0 articles left this week
USPTO Denies IPR Challenges to First Solar’s TOPCon Patents, Advancing Infringement Litigation
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The US Patent and Trademark Office director has refused to institute review of three Inter Partes Review petitions targeting First Solar’s patents on TOPCon solar cell manufacturing methods. The denied petitions, submitted by JinkoSolar, Mundra Solar, and Canadian Solar, relate to US patents acquired by First Solar th…
Share This Article
Ready-to-post copy includes the article link.

USPTO Denies IPR Challenges to First Solar’s TOPCon Patents, Advancing Infringement Litigation The US Patent and Trademark Office director has refused to institute review of three Inter Partes Review petitions targeting First Solar’s patents on TOPCon solar cell manufacturing methods. The denied petitions, submit... Read the full IIPLA article: https://iipla.org/news/uspto-denies-ipr-challenges-to-first-solar-s-topcon-patents-advancing-infringement-litigation

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

JOOLA Settles Patent Dispute with Paddletek and ProXR, Establishes Royalty Agreement

JOOLA has reached a settlement with Paddletek Group and ProXR Pickleball concerning patent infringement claims related to JOOLA's propulsion core technology. The agreement includes royalty payments and a phased discontinuation of affected products, marking a cooperative resolution five weeks after the initial lawsuit.…

Thursday, May 14, 2026
PatentsEurope

Philips Leads European Patent Office Medtech Filings in 2024 with 594 Applications

In 2024, Royal Philips emerged as the leading medical technology patent applicant at the European Patent Office, filing 594 Medtech patents. This milestone highlights Philips’ sustained investment in R&D, focusing on AI and informatics to enhance patient care and operational efficiency in hospitals and homes worldwide.

Thursday, May 14, 2026